Literature DB >> 18611096

Identifying high-risk asthma with utilization data: a revised HEDIS definition.

Antonia V Bennett1, Paula Lozano, Laura P Richardson, Elizabeth McCauley, Wayne J Katon.   

Abstract

OBJECTIVE: To develop a definition of high-risk asthma that more precisely identifies patients needing case management than the 2006 Healthcare Effectiveness Data and Information Set (HEDIS) definition. STUDY
DESIGN: Two-year claims-based study, with cross-sectional phone survey data, for a sample of 769 youths (age 11-17 years) with asthma.
METHODS: The 2006 HEDIS measure defines high-risk asthma as meeting any of the following criteria: >1 emergency department (ED) visits, > or =1 hospitalizations for asthma, > or =4 asthma medication prescriptions, or > or =4 ambulatory visits for asthma with > or =2 prescriptions for asthma medication in 1 year. We created a revised definition (> or =1 ED visits or > or =1 hospitalizations for asthma or > or =1 oral steroid prescriptions for asthma) and identified patients with high-risk asthma in year 1 according to each definition. We compared the 2 groups on demographic and clinical characteristics, and healthcare utilization and costs in years 1 and 2.
RESULTS: The revised definition identified 29% of the sample as having high-risk asthma, whereas the 2006 definition identified 67%. Compared with the 2006 definition, the revised definition identified patients with significantly greater asthma-related physical health problems and higher medical costs in year 1. In year 2, youths classified as high risk by the revised definition made more ED visits and were more likely to use oral steroids than those classified as high risk by the 2006 definition.
CONCLUSION: The revised high-risk asthma definition identifies half as many individuals and is better able to identify patients with poorly controlled asthma in the subsequent year.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18611096      PMCID: PMC2562616     

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  17 in total

1.  Development and estimation of a pediatric chronic disease score using automated pharmacy data.

Authors:  P A Fishman; D K Shay
Journal:  Med Care       Date:  1999-09       Impact factor: 2.983

2.  Pharmaceutically-based severity stratification of an asthmatic population.

Authors:  F T Leone; J R Grana; P McDermott; S MacPherson; N A Hanchak; J E Fish
Journal:  Respir Med       Date:  1999-11       Impact factor: 3.415

3.  The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey.

Authors:  P Lozano; S D Sullivan; D H Smith; K B Weiss
Journal:  J Allergy Clin Immunol       Date:  1999-11       Impact factor: 10.793

4.  Outcomes evaluation of a comprehensive intervention program for asthmatic children enrolled in medicaid.

Authors:  C S Kelly; A L Morrow; J Shults; N Nakas; G L Strope; R D Adelman
Journal:  Pediatrics       Date:  2000-05       Impact factor: 7.124

5.  Reduction in resource utilization by an asthma outreach program.

Authors:  D K Greineder; K C Loane; P Parks
Journal:  Arch Pediatr Adolesc Med       Date:  1995-04

6.  The prevalence of DSM-IV anxiety and depressive disorders in youth with asthma compared with controls.

Authors:  Wayne Katon; Paula Lozano; Joan Russo; Elizabeth McCauley; Laura Richardson; Terry Bush
Journal:  J Adolesc Health       Date:  2007-09-04       Impact factor: 5.012

7.  A multisite randomized trial of the effects of physician education and organizational change in chronic-asthma care: health outcomes of the Pediatric Asthma Care Patient Outcomes Research Team II Study.

Authors:  Paula Lozano; Jonathan A Finkelstein; Vincent J Carey; Edward H Wagner; Thomas S Inui; Anne L Fuhlbrigge; Stephen B Soumerai; Sean D Sullivan; Scott T Weiss; Kevin B Weiss
Journal:  Arch Pediatr Adolesc Med       Date:  2004-09

8.  Asthma population management: development and validation of a practical 3-level risk stratification scheme.

Authors:  Michael Schatz; Randy Nakahiro; Christine H Jones; Richard M Roth; Anita Joshua; Diana Petitti
Journal:  Am J Manag Care       Date:  2004-01       Impact factor: 2.229

9.  Design and methods of the National Cooperative Inner-City Asthma Study.

Authors:  H Mitchell; Y Senturia; P Gergen; D Baker; C Joseph; K McNiff-Mortimer; H J Wedner; E Crain; P Eggleston; R Evans; M Kattan; C Kercsmar; F Leickly; F Malveaux; E Smartt; K Weiss
Journal:  Pediatr Pulmonol       Date:  1997-10

10.  Limits of the HEDIS criteria in determining asthma severity for children.

Authors:  Michael D Cabana; Kathryn K Slish; Bin Nan; Noreen M Clark
Journal:  Pediatrics       Date:  2004-10       Impact factor: 7.124

View more
  2 in total

1.  Electronic health record-based assessment of oral corticosteroid use in a population of primary care patients with asthma: an observational study.

Authors:  Felicia C Allen-Ramey; Linda M Nelsen; Joseph B Leader; Dione Mercer; Henry Lester Kirchner; James B Jones
Journal:  Allergy Asthma Clin Immunol       Date:  2013-08-07       Impact factor: 3.406

2.  Systematic review of atopic dermatitis disease definition in studies using routinely collected health data.

Authors:  M P Dizon; A M Yu; R K Singh; J Wan; M-M Chren; C Flohr; J I Silverberg; D J Margolis; S M Langan; K Abuabara
Journal:  Br J Dermatol       Date:  2018-04-25       Impact factor: 9.302

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.